NCT06026891View on ClinicalTrials.gov

Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

January 13, 2024

Primary Completion Date

June 11, 2025

Study Completion Date

December 12, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

MG-K10/Placebo

MG-K10 Humanized Monoclonal Antibody Injection

Trial Locations (1)

Unknown

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Shanghai Mabgeek Biotech.Co.Ltd

OTHER_GOV